Find insight on Dutch payments company Adyen, Spanish bank Unicaja and more in the latest Market Talks covering Financial ...

Biotech giant Regeneron’s (REGN) performance has been pretty ho-hum in the year so far. While Eylea sales continue to be under pressure, affecting the top line, the company finally managed to post ...

Cary Street Partners Financial LLC dramatically reduced its stake in Regeneron Pharmaceuticals. The firm now holds a mere 255 ...

Michael Burry's Scion Asset Management switched out a bet against Nvidia for a wager on Meta as it overhauled its stock ...

Burry, known as the "Big Short" investor for his prescient calls ahead of the 2008 U.S. housing market crash, placed bets ...

The directive calls for building a six-month Strategic Active Pharmaceutical Ingredients Reserve, updating the essential ...

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

New research co-led by Mass Eye and Ear demonstrates that a single-dose gene editing therapy using CRISPR-Cas9 can safely and ...

Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly ...

One of the companies mentioned in the letter is Regeneron Pharmaceuticals Inc. (NASDAQ:REGN). Regeneron Pharmaceuticals Inc. ...

Swiss National Bank trimmed its stake in Regeneron Pharmaceuticals, Inc. by a modest 0.5%. Despite this, Regeneron's share ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of the top most undervalued biotech stocks to buy now. Guggenheim ...